KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Change in Inventory: 2016-2025

Historic Change in Inventory for Sarepta Therapeutics (SRPT) over the last 9 years, with Sep 2025 value amounting to $83.0 million.

  • Sarepta Therapeutics' Change in Inventory rose 17.69% to $83.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $481.2 million, marking a year-over-year increase of 46.89%. This contributed to the annual value of $395.2 million for FY2024, which is 167.52% up from last year.
  • Sarepta Therapeutics' Change in Inventory amounted to $83.0 million in Q3 2025, which was up 40.26% from $59.2 million recorded in Q2 2025.
  • Sarepta Therapeutics' 5-year Change in Inventory high stood at $177.4 million for Q1 2025, and its period low was $306,000 during Q1 2023.
  • Its 3-year average for Change in Inventory is $78.4 million, with a median of $70.5 million in 2024.
  • Its Change in Inventory has fluctuated over the past 5 years, first slumped by 93.47% in 2023, then soared by 19,675.16% in 2024.
  • Sarepta Therapeutics' Change in Inventory (Quarterly) stood at $27.3 million in 2021, then tumbled by 67.43% to $8.9 million in 2022, then skyrocketed by 959.73% to $94.1 million in 2023, then skyrocketed by 71.79% to $161.7 million in 2024, then climbed by 17.69% to $83.0 million in 2025.
  • Its Change in Inventory was $83.0 million in Q3 2025, compared to $59.2 million in Q2 2025 and $177.4 million in Q1 2025.